Early and Aggressive Treatment May Modify Anti-Hu Associated Encephalitis Prognosis
Neuropediatrics · 01.02.2023 · 54 (01) · 064-067
DOI: 10.1055/a-1896-6687 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropediatrics, erschienen am 01.02.2023. Verfasst von Perrine Marion und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Neurology Department, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Le Kremlin Bicêtre, Fr…. Hauptthemen laut MEDLINE: Encephalitis, Nervous System Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Anti-Hu encephalitis is a paraneoplastic syndrome in adults. In children, rare cases of anti-Hu encephalitis were reported mostly without underlying tumors and clinical outcome are usually severe. Here, we describe a 4-year-old girl who developed cerebellar syndrome with abnormal behavior. The brain magnetic resonance imaging showed several T2/fluid-attenuated inversion recovery bilateral brain lesions and autoimmune assessment showed positive anti-Hu antibodies. Computed tomography scan revealed ganglioneuroblastoma which was surgically removed 3 months after onset. Aggressive immunotherapy including dexamethasone, rituximab, and intravenous immunoglobulins were used and a marked neurological improvement soon after 9 months of onset was observed with the child being able to go back to school. The short delay between diagnosis and start of aggressive immunotherapy demonstrate the paramount importance of early diagnosis and early specific therapy after onset of symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pediatric Neurology Department, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Le Kremlin Bicêtre, France.
- Pediatric Neurologic Department, National Referral Center for Rare Brain and Spinal Diseases, Le Kremlin-Bicêtre, France.
- Inserm UMR 1184, Immunology of Viral Infections and Autoimmune Diseases, CEA, IDMIT, Le Kremlin Bicêtre, France.
ORCID-Profile: Kumaran Deiva
Zitieren
APA
Marion, P., Chalus, A., Giorgi, L., Bellesme, C., Crétien, P., Maurey, H., & Deiva, K. (2023). Early and Aggressive Treatment May Modify Anti-Hu Associated Encephalitis Prognosis. Neuropediatrics, 54(01), 064-067. https://doi.org/10.1055/a-1896-6687
Vancouver
Marion P, Chalus A, Giorgi L, Bellesme C, Crétien P, Maurey H, et al. Early and Aggressive Treatment May Modify Anti-Hu Associated Encephalitis Prognosis. Neuropediatrics. 2023;54(01):064-067. doi:10.1055/a-1896-6687
BibTeX
@article{Marion2023,
author = {Marion, Perrine and Chalus, Aliénor De and Giorgi, Laetitia and Bellesme, Céline and Crétien, Pascale and Maurey, Hélène and Deiva, Kumaran},
title = {Early and Aggressive Treatment May Modify Anti-Hu Associated Encephalitis Prognosis},
journal = {Neuropediatrics},
year = {2023},
volume = {54},
number = {01},
pages = {064--067},
doi = {10.1055/a-1896-6687}
}
EUVIMED